Apply now: Bristol Myers Squibb’s Golden Ticket—$50K lab credit to LabCentral >

All Press Releases

Vedanta Biosciences Announces License Agreement with RIKEN and other Japanese Institutions for New Immune Boosting Microbiome Technology April 1, 2016

Bristol-Myers Squibb and LabCentral Team Up in Cambridge, Massachusetts to Support Promising Biotech Startup Companies March 7, 2016

Yumanity Therapeutics Closes $45 Million Series A Financing February 10, 2016

Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline January 26, 2016

Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda Pharmaceuticals To Advance New Therapies in ALS December 21, 2015

Navitor Pharmaceuticals Announces $33 Million Series B Financing December 18, 2015

Arsia Therapeutics Inc. and Biogen Sign a Research Collaboration for the Development of Subcutaneous Biologics December 16, 2015

Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma December 14, 2015

Aquinnah Pharmaceuticals Receives $680,000 Grant from NINDS To Advance New Therapies for ALS November 23, 2015

Jackson Laboratory Spinout Cyteir Therapeutics Announces $5.5 Million Series A Financing Round and Appointment of Donald F. Corcoran as President and Chief Executive Officer November 5, 2015

1 ... 17 18 19 ... 22